Impact Biomedical (IBO) Tax Rate (2022)
Impact Biomedical (IBO) posted Tax Rate of 35.82% for Q4 2022, up 127.85% on a QoQ basis from 128.63% in Q3 2022.
Impact Biomedical (IBO) Tax Rate (2022) Analysis & Trends
Impact Biomedical's Tax Rate history runs 1 years deep, the most recent figure standing at 35.82% for Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 35.82% |
| Dec 31, 2022 | 35.82% |
| Dec 31, 2022 | 35.82% |
| Sep 30, 2022 | -128.63% |
| Sep 30, 2022 | -128.63% |
| Sep 30, 2022 | -128.63% |